Results

RDF/XMLNTriplesTurtleShow queryShare ▶
SubjectPredicateObject
http://purl.uniprot.org/citations/29715092http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/29715092http://www.w3.org/2000/01/rdf-schema#comment"

Background/aim

Therapeutic options of locally advanced or metastatic head and neck squamous cell carcinoma (HNSCC) are limited. Src and cKIT are key protein regulators for local tumor progression. The aim of the study was to investigate the therapeutic potential of targeted therapies in human squamous cell carcinoma (HNSCC) in vitro. Therefore, the influence of the selective tyrosine kinase inhibitors niotinib, dasatinib, erlotinib, gefitinib and afatinib on Src and cKIT expression in Human papilloma virus (HPV)-positive and HPV-negative squamous cancer cells (SCC) was analyzed in vitro.

Materials and methods

ELISA was performed to evaluate the expression of Src and cKIT under the influence of nilotinib, dasatinib, erlotinib, gefitinib and afatinib (10 μmol/l) in HPV-negative and HPV-positive SCC (24-96 h of incubation).

Results

Gefitinib significantly increased cKIT expression in HPV-positive and HPV-negative cells whereas nilotinib and afatinib decreased cKIT expression in HPV-positive SCC. The influence of tyrosine kinase inhibitors in HPV-negative SCC was marginal. Surprisingly, Src expression was significantly increased by all tested tyrosine kinase inhibitors in HPV-positive SCC.

Conclusion

The results revealed beneficial and unexpected information concerning the interaction of selective tyrosine kinase inhibitors and the tumor biology of HNSCC."xsd:string
http://purl.uniprot.org/citations/29715092http://purl.org/dc/terms/identifier"doi:10.21873/anticanres.12514"xsd:string
http://purl.uniprot.org/citations/29715092http://purl.uniprot.org/core/author"Kramer B."xsd:string
http://purl.uniprot.org/citations/29715092http://purl.uniprot.org/core/author"Birk R."xsd:string
http://purl.uniprot.org/citations/29715092http://purl.uniprot.org/core/author"Aderhold C."xsd:string
http://purl.uniprot.org/citations/29715092http://purl.uniprot.org/core/author"Kneissle M."xsd:string
http://purl.uniprot.org/citations/29715092http://purl.uniprot.org/core/author"Rotter N."xsd:string
http://purl.uniprot.org/citations/29715092http://purl.uniprot.org/core/date"2018"xsd:gYear
http://purl.uniprot.org/citations/29715092http://purl.uniprot.org/core/name"Anticancer Res"xsd:string
http://purl.uniprot.org/citations/29715092http://purl.uniprot.org/core/pages"2723-2731"xsd:string
http://purl.uniprot.org/citations/29715092http://purl.uniprot.org/core/title"Tyrosine Kinase Inhibition in HPV-related Squamous Cell Carcinoma Reveals Beneficial Expression of cKIT and Src."xsd:string
http://purl.uniprot.org/citations/29715092http://purl.uniprot.org/core/volume"38"xsd:string
http://purl.uniprot.org/citations/29715092http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/29715092
http://purl.uniprot.org/citations/29715092http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/29715092
http://purl.uniprot.org/uniprot/#_A0A0U2N547-mappedCitation-29715092http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/29715092
http://purl.uniprot.org/uniprot/#_A0A8I5KR87-mappedCitation-29715092http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/29715092
http://purl.uniprot.org/uniprot/#_E2I6G0-mappedCitation-29715092http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/29715092
http://purl.uniprot.org/uniprot/#_B6DXN3-mappedCitation-29715092http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/29715092
http://purl.uniprot.org/uniprot/#_B6E0M6-mappedCitation-29715092http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/29715092
http://purl.uniprot.org/uniprot/#_D5MAV8-mappedCitation-29715092http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/29715092
http://purl.uniprot.org/uniprot/#_D5MAV9-mappedCitation-29715092http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/29715092
http://purl.uniprot.org/uniprot/#_Q14925-mappedCitation-29715092http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/29715092
http://purl.uniprot.org/uniprot/#_Q15999-mappedCitation-29715092http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/29715092
http://purl.uniprot.org/uniprot/#_Q14708-mappedCitation-29715092http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/29715092
▶